Valuation: RaySearch Laboratories AB

Market Cap 6.42B 675M 583M 548M 499M 937M 64.57B 951M 2.51B 32.32B 2.54B 2.48B 109B P/E 2026 *
23.9x
P/E 2027 * 19.2x
Enterprise Value 6.58B 692M 597M 561M 511M 960M 66.13B 974M 2.57B 33.1B 2.6B 2.54B 111B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 3.94x
Free-Float
80.09%
Yield 2026 *
2.09%
Yield 2027 * 2.5%
1 day-2.11%
1 week+5.57%
Current month+4.97%
1 month+12.68%
3 months+7.35%
6 months+3.11%
Current year-16.61%
1 week 187.2
Extreme 187.2
199.8
1 month 164.55
Extreme 164.55
199.8
Current year 161
Extreme 161
237
1 year 161
Extreme 161
274.5
3 years 63.1
Extreme 63.1
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.11%+5.57% - - 700M
Average -2.11%
Weighted average by Cap. -2.11%

Financials

2026 *2027 *
Net sales 1.4B 147M 127M 119M 108M 204M 14.04B 207M 546M 7.03B 551M 539M 23.6B 1.63B 172M 148M 139M 127M 238M 16.4B 241M 638M 8.21B 644M 630M 27.57B
Net income 272M 28.6M 24.7M 23.19M 21.11M 39.69M 2.73B 40.26M 106M 1.37B 107M 105M 4.6B 338M 35.48M 30.64M 28.78M 26.2M 49.25M 3.39B 49.96M 132M 1.7B 133M 130M 5.7B
Net Debt 155M 16.3M 14.07M 13.22M 12.03M 22.62M 1.56B 22.94M 60.65M 780M 61.18M 59.85M 2.62B 7M 736K 636K 597K 543K 1.02M 70.35M 1.04M 2.74M 35.22M 2.76M 2.7M 118M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
17/08/26 SEK 190.60 -1.90% 16,574
14/08/26 SEK 194.30 +2.18% 24,757
13/08/26 SEK 190.15 -0.34% 12,431
12/08/26 SEK 190.80 -0.93% 13,190
11/08/26 SEK 192.60 +1.20% 1,909
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
191.10SEK
Average target price
297.50SEK
Spread / Average Target
+55.68%

Quarterly revenue - Rate of surprise